Centrient Pharmaceuticals
Victor Zamora is an experienced professional with over 25 years in the pharmaceutical industry. Currently serving as Country President & Commercial Director West at Centrient Pharmaceuticals since March 1997, Victor is responsible for managing operations in Mexico and Latin America, driving strategic planning and execution, and ensuring effective collaboration across teams. Previous roles at Centrient include Managing Director, Marketing Director, Sales Manager, Demand and Supply Chain Manager, Logistics Manager, Transportation & Planning Superintendent, and Customer Service Agent. Prior to Centrient, Victor held the position of Export Chief at Nacional de Cerámica SA de CV. Victor holds a Master’s degree in Business Administration and Management from Universidad Iberoamericana and a Bachelor's degree in Marketing from Tecnológico de Monterrey.
This person is not in any teams
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.